Patient iMGs carrying GRN–LOF variants show increased expression of SORT1 and TMEM106B compared to control iMGs (Fig. 4H), consistent with increased TMEM106B in brains of patients diagnosed with FTD [43]. This evidence concerns the gene SORT1 and frontotemporal dementia.